BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

320 related articles for article (PubMed ID: 32030795)

  • 21. A long noncoding RNA AB073614 promotes tumorigenesis and predicts poor prognosis in ovarian cancer.
    Cheng Z; Guo J; Chen L; Luo N; Yang W; Qu X
    Oncotarget; 2015 Sep; 6(28):25381-9. PubMed ID: 26299803
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Cross-validation of genes potentially associated with overall survival and drug resistance in ovarian cancer.
    Gao Y; Liu X; Li T; Wei L; Yang A; Lu Y; Zhang J; Li L; Wang S; Yin F
    Oncol Rep; 2017 May; 37(5):3084-3092. PubMed ID: 28350120
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Identification of immune microenvironment subtypes that predicted the prognosis of patients with ovarian cancer.
    Wang X; Li X; Wang X
    J Cell Mol Med; 2021 Apr; 25(8):4053-4061. PubMed ID: 33675171
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Long noncoding RNA ZFPM2-AS1 acts as a miRNA sponge and promotes cell invasion through regulation of miR-139/GDF10 in hepatocellular carcinoma.
    He H; Wang Y; Ye P; Yi D; Cheng Y; Tang H; Zhu Z; Wang X; Jin S
    J Exp Clin Cancer Res; 2020 Aug; 39(1):159. PubMed ID: 32795316
    [TBL] [Abstract][Full Text] [Related]  

  • 25. High coexpression of CCL2 and CX3CL1 is gender-specifically associated with good prognosis in soft tissue sarcoma patients.
    Kehlen A; Greither T; Wach S; Nolte E; Kappler M; Bache M; Holzhausen HJ; Lautenschläger C; Göbel S; Würl P; Immel UD; Agaimy A; Wullich B; Taubert H
    Int J Cancer; 2014 Nov; 135(9):2096-106. PubMed ID: 24676787
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Long non-coding RNA PVT1-mediated miR-543/SERPINI1 axis plays a key role in the regulatory mechanism of ovarian cancer.
    Qu C; Dai C; Guo Y; Qin R; Liu J
    Biosci Rep; 2020 Jun; 40(6):. PubMed ID: 32441301
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Upregulation of long intergenic noncoding RNA 00673 promotes tumor proliferation via LSD1 interaction and repression of NCALD in non-small-cell lung cancer.
    Shi X; Ma C; Zhu Q; Yuan D; Sun M; Gu X; Wu G; Lv T; Song Y
    Oncotarget; 2016 May; 7(18):25558-75. PubMed ID: 27027352
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The Chemokine CX3CL1 Improves Trastuzumab Efficacy in HER2 Low-Expressing Cancer
    Dreyer TF; Kuhn S; Stange C; Heithorst N; Schilling D; Jelsma J; Sievert W; Seitz S; Stangl S; Hapfelmeier A; Noske A; Wege AK; Weichert W; Ruland J; Schmitt M; Dorn J; Kiechle M; Reuning U; Magdolen V; Multhoff G; Bronger H
    Cancer Immunol Res; 2021 Jul; 9(7):779-789. PubMed ID: 33906866
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Analysis of competing endogenous RNA network identifies a poorly differentiated cancer-specific RNA signature for hepatocellular carcinoma.
    Chen QF; Huang T; Si-Tu QJ; Wu P; Shen L; Li W; Huang Z
    J Cell Biochem; 2020 Mar; 121(3):2303-2317. PubMed ID: 31642123
    [TBL] [Abstract][Full Text] [Related]  

  • 30. LncRNA GIHCG promotes development of ovarian cancer by regulating microRNA-429.
    Yao N; Yu L; Zhu B; Gan HY; Guo BQ
    Eur Rev Med Pharmacol Sci; 2018 Dec; 22(23):8127-8134. PubMed ID: 30556850
    [TBL] [Abstract][Full Text] [Related]  

  • 31. NCK1-AS1 promotes NCK1 expression to facilitate tumorigenesis and chemo-resistance in ovarian cancer.
    Chang H; Li B; Zhang X; Meng X
    Biochem Biophys Res Commun; 2020 Feb; 522(2):292-299. PubMed ID: 31761329
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Linc00161 regulated the drug resistance of ovarian cancer by sponging microRNA-128 and modulating MAPK1.
    Xu M; Zhou K; Wu Y; Wang L; Lu S
    Mol Carcinog; 2019 Apr; 58(4):577-587. PubMed ID: 30556928
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Long noncoding RNA WDFY3-AS2 suppresses tumor progression by acting as a competing endogenous RNA of microRNA-18a in ovarian cancer.
    Li W; Ma S; Bai X; Pan W; Ai L; Tan W
    J Cell Physiol; 2020 Feb; 235(2):1141-1154. PubMed ID: 31347170
    [TBL] [Abstract][Full Text] [Related]  

  • 34. PAXIP1-AS1 is associated with immune infiltration and predicts poor prognosis in ovarian cancer.
    Chen B; Lu X; Zhou Q; Chen Q; Zhu S; Li G; Liu H
    PLoS One; 2023; 18(8):e0290031. PubMed ID: 37582104
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The lncRNA 'UCA1' modulates the response to chemotherapy of ovarian cancer through direct binding to miR-27a-5p and control of UBE2N levels.
    Wambecke A; Ahmad M; Morice PM; Lambert B; Weiswald LB; Vernon M; Vigneron N; Abeilard E; Brotin E; Figeac M; Gauduchon P; Poulain L; Denoyelle C; Meryet-Figuiere M
    Mol Oncol; 2021 Dec; 15(12):3659-3678. PubMed ID: 34160887
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Long Noncoding RNA SCAMP1 Targets miR-137/CXCL12 Axis to Boost Cell Invasion and Angiogenesis in Ovarian Cancer.
    Song R; Liu Z; Lu L; Liu F; Zhang B
    DNA Cell Biol; 2020 Jun; 39(6):1041-1050. PubMed ID: 32401536
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Upregulation of the long non-coding RNA SPRY4-IT1 indicates a poor prognosis and promotes tumorigenesis in ovarian cancer.
    Li H; Liu C; Lu Z; Chen L; Wang J; Li Y; Ma H
    Biomed Pharmacother; 2017 Apr; 88():529-534. PubMed ID: 28129625
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Long noncoding RNA LINC00152 promotes cell proliferation through competitively binding endogenous miR-125b with MCL-1 by regulating mitochondrial apoptosis pathways in ovarian cancer.
    Chen P; Fang X; Xia B; Zhao Y; Li Q; Wu X
    Cancer Med; 2018 Sep; 7(9):4530-4541. PubMed ID: 30030896
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Downregulated Long Noncoding RNA DGCR5 Acts as a New Promising Biomarker for the Diagnosis and Prognosis of Ovarian Cancer.
    Chen H; Tian X; Luan Y; Lu H
    Technol Cancer Res Treat; 2019; 18():1533033819896809. PubMed ID: 31868103
    [TBL] [Abstract][Full Text] [Related]  

  • 40. LINC01342 promotes the progression of ovarian cancer by absorbing microRNA-30c-2-3p to upregulate HIF3A.
    Zhang C; Liu J; Zhang Y; Luo C; Zhu T; Zhang R; Yao R
    J Cell Physiol; 2020 Apr; 235(4):3939-3949. PubMed ID: 31595977
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 16.